Best AI Drug Discovery Newsletters in 2026
NewsletterFIT tracks 5 newsletters that cover AI drug discovery as a primary topic, 4 of them with posts in the last 90 days. By publicly shown subscriber count, the largest are Where Tech Meets Bio (12K), Robonomics (3K) and MetaphysicalCells (1K).
Updated Nov 15, 2026 · sorted by publicly shown subscribers · methodology
- 1Where Tech Meets Bio12K subscribers
SubstackWeekly · last post 4 days ago
What does the future hold for us in the "century of biotech"?
Likely audience: Venture capitalists
Sponsors detected:
- 2Robonomics3K subscribers
SubstackWeekly · last post 14 days ago
From recent posts: Robonomics publishes weekly data-driven analyses on AI infrastructure, compute scaling, and market dynamics for investors and industry observers. The publication covers topics ranging from global semiconductor supply…
Likely audience: AI infrastructure investors
- 3MetaphysicalCells1K subscribers
SubstackSeveral times a week · last post 10 days ago
From recent posts: The article reports on biotech partnerships and funding in AI drug discovery, including Celea contracting Qureight for imaging CRO services, Curacle and Standigm receiving South Korean government R&D funding for an IPF…
Likely audience: Biotech investors
- 4
LinkedInEvery two weeks · last post 32 days ago
Stay up-to-date on cutting edge news and advancements in the precision medicine space.
Likely audience: life sciences investors
- 5
Substacklast post Jan 28, 2026
A newsletter on AI insights for business leaders, board members, and investors. Get concise, actionable tools and news to elevate your strategy and decision-making.
Likely audience: Business leaders
Latest posts from these newsletters
- Weekly Tech+Bio…Where Tech Meets Bio
- The Virtual…Where Tech Meets Bio
- Latest News…MetaphysicalCells
- Weekly Tech+Bio…Where Tech Meets Bio
- Notable TechBio…MetaphysicalCells
- Robotics' New…Robonomics
- AIDD |…Robonomics
- Fact Check…Robonomics